BiotechTube
Home/Mwyngil Therapeutics/Srini Natala PhD
SN

Srini Natala PhD

Lead Medicinal Chemistry

Mwyngil Therapeutics

Therapeutic Areas

ObesityChronic Kidney DiseaseInflammatory DiseasesNeurodegenerationCardiovascular Disease

Mwyngil Therapeutics Pipeline

DrugIndicationPhase
MW-504Obesity, Chronic Kidney DiseasePreclinical
MW-313Chronic Kidney Disease, Cardiovascular DiseasePreclinical
MW-401Obesity, Chronic Kidney DiseasePreclinical

Leadership Team at Mwyngil Therapeutics

NS
Nikolay Savchuk PhD
CEO
VK
Vasily Kazey PhD
Head of Pharmacology
AK
Alexander Khvat PhD
Head of Medicinal Chemistry
CF
Claudia Filozof MD PhD
Head of Clinical Development (interim)
BR
Boris Rogovoy PhD
Head of Chemistry
SM
Steph Mowery PhD
Head of Biology
RK
Ruben Karapetyan PhD
Head of Development
View full Mwyngil Therapeutics profile